Optimization of the Production Technology of Oxidized Cyclodextrin Bisulfite
Abstract
:1. Introduction
- -
- N-Sulfonate derivatives of poly(allylamine)hydrochloride with molecular mass of 56 kDa and a degree of substitution of 98%, which show strong antiviral activity against replications of influenza A virus in vitro and ex vivo mainly in the late infection stages [16];
- -
- Polyanionic low molecular (<10 kDa) sulfonate polymers, e.g., copolymers of urea and biphenyldisulfonic acid: Poly{imino[2,2′-disulfo(1,1′-biphenyl)-4,4′-diyl]iminocarbonyl-1,4-phenylen-carbonyl} possessing antiviral activity against enveloped viruses, such herpes and human immunodeficiency viruses [17,18].
2. Materials and Methods
2.1. Reagents
2.2. Laboratory Procedure for the Synthesis of Substance KS-6469
2.3. Scaled-Up Procedure for the Synthesis of Substance KS-6469 in Pilot Plants
2.4. Methods of Instrumental Analysis
3. Results and Discussion
- (Auxiliary work) AW-1.5: Purification of C2H5OH
- (Technological process) TP-2.1: Oxidation of β-CD
- TP-2.3: Purification of low molecular weight impurities (dialysis)
- TP-2.4: Isolation of the target product
- TP-2.5: Drying in vacuum.
3.1. Optimization of Stage TP-2.4 the Isolation of the Target Product
3.1.1. Freezing
3.1.2. Primary Drying (Ice Sublimation)
3.1.3. Final Drying (Removal of Residual Moisture)
3.2. Optimization of Stage TP-2.3 Purification from Low Molecular Weight Impurities (Dialysis)
3.3. Optimization of Stage TP-2.1 Oxidation of β-CD
- T = 45 °C; t = 18 h
- T = 80 °C; t = 1.5 h.
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Global Influenza Strategy 2019–2030. Available online: https://www.who.int/influenza/en/ (accessed on 17 April 2019).
- Samson, M.; Pizzorno, A.; Abed, Y.; Boivin, G. Influenza virus resistance to neuraminidase inhibitors. Antiviral Res. 2013, 98, 174–185. [Google Scholar] [CrossRef] [PubMed]
- Scholtissek, C.; Quack, G.; Klenk, H.D.; Webster, R.G. How to overcome resistance of influenza a viruses against adamantane derivatives. Antiviral Res. 1998, 37, 83–95. [Google Scholar] [CrossRef]
- Woodhead, M.; Lavanchy, D.; Johnston, S.; Colman, P.; Fleming, D. Neuraminidase inhibitors: Progress in the management of influenza. Int. J. Clin. Pract. 2000, 54, 604–610. [Google Scholar]
- O’Malley, P. Intravenous peramivir emergency use authorization 2009: Update for the clinical nurse specialist. Clin. Nurse Spec. 2010, 24, 51–53. [Google Scholar] [CrossRef] [PubMed]
- Fiore, A.E.; Fry, A.; Shay, D.; Gubareva, L.; Bresee, J.S.; Uyeki, T.M. Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 2011, 60, 1–24. [Google Scholar] [PubMed]
- Fitton, J.H. Therapies from fucoidan; Multifunctional marine polymers. Mar. Drugs 2011, 9, 1731–1760. [Google Scholar] [CrossRef] [PubMed]
- Leibbrandt, A.; Meier, C.; König-Schuster, M.; Weinmüllner, R.; Kalthoff, D.; Pflugfelder, B.; Graf, P.; Frank-Gehrke, B.; Beer, M.; Fazekas, T.; et al. Iota-carrageenan is a potent inhibitor of influenza A virus infection. PLoS ONE 2010, 5, e14320. [Google Scholar] [CrossRef] [PubMed]
- Grassauer, A.; Weinmuellner, R.; Meier, C.; Pretsch, A.; Prieschl-Grassauer, E.; Unger, H. Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol. J. 2008, 5, 107. [Google Scholar] [CrossRef]
- Tang, F.; Chen, F.; Li, F. Preparation and potential in vivo anti-influenza virus activity of low molecular-weight κ-carrageenans and their derivatives. J. Appl. Polym. Sci. 2013, 127, 2110–2115. [Google Scholar] [CrossRef]
- Kostyro, Y.A.; Goncharova, E.P.; Soldatenko, A.S.; Zenkova, M.A.; Vlasov, V.V.; Ivanov, A.V. Means with antiviral activity against influenza virus. Assignees: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, The A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch of the Russian Academy of Sciences. RU Patent 2,635,765, 15 November 2017. [Google Scholar]
- Guthrie, R.D. Periodate Oxidation. Experimental conditions. In Methods in Carbohydrate Chemistry: Analysis and Preparation of Sugars; Whistler, R.L., Wolfrom, M.L., Eds.; Academic Press: New York, NY, USA, 1962; Volume 1, pp. 432–435. [Google Scholar]
- Ingles, D.L. Chemistry of non-enzymic browning. V. The preparation of Aldose-Potassium bisulphite addition compounds and some amine derivatives. Aust. J. Chem. 1959, 12, 97–101. [Google Scholar]
- Linhardt, R.J.; Toida, T. Heparin oligosaccharides: New analogues development and applications. In Carbohydrates in Drug Design; Witczak, Z.J., Nieforth, K.A., Eds.; Marcel Dekker: New York, NY, USA, 1997; pp. 277–341. [Google Scholar]
- Kisilevsky, R.; Lemieux, L.J.; Fraser, P.E.; Kong, X.; Hultin, P.G.; Szarek, W.A. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: Implications for Alzheimer’s disease. Nat. Med. 1995, 1, 143–148. [Google Scholar] [CrossRef] [PubMed]
- Ciejka, J.; Milewska, A.; Wytrwal, M.; Wojarski, J.; Golda, A.; Ochman, M.; Nowakowska, M.; Szczubialka, K.; Pyrc, K. Novel polyanions inhibiting replication of influenza viruses. Antimicrob. Agents Chemother. 2016, 60, 1955–1966. [Google Scholar] [CrossRef] [PubMed]
- Cardin, A.D.; Jackson, R.L.; Mullins, M.J. Anti-herpes virus and cytomegalovirus polyamide oligomers. Assignees: Merrell Pharmaceuticals Inc. (Cincinnati, OH), The Dow Chemical Co. (Midland, MI). US Patent 5728731A, 17 March 1998. [Google Scholar]
- Ahmed, S.P.; Cardin, A.D.; Bridges, C.G.; Jackson, R.L.; Mullins, M.J.; Tyms, A.S. Potent inhibition of herpes simplex virus by MDL 101028, a Novel biphenyl disulfonic acid urea co-polymer. Antiviral. Chem. Chemother. 1995, 6, 34–42. [Google Scholar] [CrossRef]
- Sadikoglu, H.; Ozdemir, M.; Seker, M. Freeze-drying of pharmaceutical products: Research and development needs. Dry. Technol. 2006, 24, 849–861. [Google Scholar] [CrossRef]
- Tang, X.C.; Pikal, M.J. Design of freeze-drying processes for pharmaceuticals: Practical advice. Pharm. Res. 2004, 21, 191–200. [Google Scholar] [CrossRef] [PubMed]
- Patapoff, T.W.; Overcashier, D.E. The importance of freezing on lyophilization cycle development. BioPharm 2002, 15, 16–21. [Google Scholar]
- Kasper, J.C.; Friess, W. The freezing step in lyophilization: Physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. Eur. J. Pharm. Biopharm. 2011, 78, 248–263. [Google Scholar] [CrossRef] [PubMed]
- Chouvenc, P.; Vessot, S.; Andrieu, J.; Vacus, P. Optimization of the freeze-drying cycle: A new model for pressure rise analysis. Dry. Technol. 2004, 22, 1577–1601. [Google Scholar] [CrossRef]
- Ganguly, A.; Nail, S.L.; Alexeenko, A.A. Rarefied gas dynamics aspects of pharmaceutical freeze-drying. Vacuum 2012, 86, 1739–1747. [Google Scholar] [CrossRef]
- Tang, X.C.; Nail, S.L.; Pikal, M.J. Freeze-drying process design by manometric temperature measurement: Design of a smart freeze-dryer. Pharm. Res. 2005, 22, 685–700. [Google Scholar] [CrossRef]
- Trelea, I.C.; Passot, S.; Fonseca, F.; Marin, M. An interactive tool for the optimization of freeze-drying cycles based on quality criteria. Dry. Technol. 2007, 25, 741–751. [Google Scholar] [CrossRef]
- Wei, W.; Mo, C.; Guohua, C. Issues in freeze drying of aqueous solutions. Chin. J. Chem. Eng. 2012, 20, 551–559. [Google Scholar] [CrossRef]
- Jönsson, A.-S.; Trägårdh, G. Fundamental principles of ultrafiltration. Chem. Eng. Process. 1990, 27, 67–81. [Google Scholar] [CrossRef]
- Kuriyel, R.; Fushijima, M.; Jung, C.W. Advancements in membrane processes for pharmaceutical applications. In Handbook of Membrane Separations: Chemical, Pharmaceutical, Food and Biotechnological Applications, 2nd ed.; Pabby, A.K., Rizvi, S.S.H., Sastre, A.M., Eds.; CRC Press: Boca Raton, FL, USA, 2015; pp. 403–418. [Google Scholar]
- Davis, R.H. Theory of cross-flow filtration. In Membrane Handbook; Winston Ho, W.S., Sirkar, K.K., Eds.; Van Nostrand Reinhold: New York, NY, USA, 1992; pp. 480–505. [Google Scholar]
- Genovesi, C.S. Several uses for tangential-flow filtration in the pharmaceutical industry. PDA J. Pharm. Sci. Technol. 1983, 37, 81–86. [Google Scholar]
- Dixon, J.S.; Lipkin, D. Spectrophotometric determination of vicinal glycols. Anal. Chem. 1954, 26, 1092–1093. [Google Scholar] [CrossRef]
- Marnett, L.J.; Bienkowski, M.J.; Raban, M.; Tuttle, M.A. Studies of the hydrolysis of 14C-labeled tetraethoxypropane to malondialdehyde. Anal. Biochem. 1979, 99, 458–463. [Google Scholar] [CrossRef]
- Crouthamel, C.E.; Meek, H.V.; Martin, D.S.; Banks, C.V. Spectrophotometric studies of dilute aqueous periodate solutions. J. Am. Chem. Soc. 1949, 71, 3031–3035. [Google Scholar] [CrossRef]
Entry | Process Parameters | Reaction Time | Consumption of NaIO4 (mol/mol β-CD/% to Theoretically Possible) | The Presence of the Absorption of the Reaction Mixture to the End of the Reaction at λmax = 245 nm and λmax = 267 nm |
---|---|---|---|---|
1 | T = 20 °C t = 120 h | 95–100 h | 6.23 ± 0.31 mol/89.0% | Not detected |
2 | T = 45 °C t = 18 h | 17–18 h | 6.16 ± 0.29 mol/87.9% | Not detected |
3 | T = 80 °C t = 1.5 h | 1.25–1.5 h | 6.84 ± 0.34 mol/97.7% | Not detected |
Compound/Empirical Formula | Process Parameters | Yield (%) | Moisture Content (%) | Mw (kDa) Found Calculated | IR (cm−1) | Found Calculated (%) | |||
---|---|---|---|---|---|---|---|---|---|
C | H | S | Na | ||||||
β-CD (C6H10O5)7 | - | - | 13.46 | 1.135 | - | 39.23 44.41 | 6.65 6.17 | - | - |
1a (C6H10Na2O11S2)7 | T = 20 °C; t = 120 h | 60 | 10.71 | 3.112 2.576 | 1311, 1144, 625 (C–SO3−) | 20.74 19.57 | 3.31 2.72 | 14.85 17.39 | 10.84 12.50 |
1b (C6H10Na2O11S2)7 | T = 45 °C; t = 18 h | 98 | 7.85 | 3.263 2.576 | 1314, 1143, 626 (C–SO3−) | 20.34 19.57 | 2.39 2.72 | 14.14 17.39 | 11.98 12.50 |
1c (C6H10Na2O11S2)7 | T = 80 °C; t = 1.5 h | 96 | 7.69 | 3.187 2.576 | 1321, 1149, 626 (C–SO3−) | 20.11 19.57 | 2.68 2.72 | 13.67 17.39 | 11.02 12.50 |
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kostyro, Y.-Y.; Soldatenko, A.; Levchuk, A. Optimization of the Production Technology of Oxidized Cyclodextrin Bisulfite. Processes 2019, 7, 426. https://doi.org/10.3390/pr7070426
Kostyro Y-Y, Soldatenko A, Levchuk A. Optimization of the Production Technology of Oxidized Cyclodextrin Bisulfite. Processes. 2019; 7(7):426. https://doi.org/10.3390/pr7070426
Chicago/Turabian StyleKostyro, Yana-Ya, Anastasiya Soldatenko, and Alexey Levchuk. 2019. "Optimization of the Production Technology of Oxidized Cyclodextrin Bisulfite" Processes 7, no. 7: 426. https://doi.org/10.3390/pr7070426